BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Biotech Companies Team Up to Design New Proteins with ML

  Arzeda, Cyrus Biotechnology and Outpace Bio, are teaming up to use machine learning and optimize protein folding and design efforts.

  June 28, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Business

  Dr. Pearl Huang Named CEO of Novartis-Backed Dunad Therapeutics (Updated)

  Pearl Huang, Ph.D, has been appointed the CEO of U.K.-based Dunad Therapeutics, a Novartis-backed biopharmaceutical startup.

  June 28, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  Ascletis Embarks on Mid-stage Study of Potentially Functional Cure for HIV

  Ascletis has commenced its Phase II trial in China for its candidate drug ASC22 alongside anti-retroviral therapy for the functional cure and immune restoration of HIV-1 infection.

  June 28, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Biogen Community Lab 2.0 Reveals Wonders of Science to Thousands of Students

  Biogen’s Chirfi Guindo discusses the launch of the company’s next-generation approach to teaching STEM to even more students, leading to potential careers in the field.

  June 28, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  Novartis Reveals Restructure will Cost up to 8,000 Jobs

  Swiss biopharma giant Novartis plans to cut up to 8,000 jobs in hopes of saving at least $1 billion by 2024.

  June 28, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  New Study: COVID-19 May Cause or Accelerate Neurological Diseases

  Danish researchers published a study suggesting that COVID-19 increases the risk of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.

  June 28, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Eiger’s HDV Program Sees Cirrhosis in Younger Patients (Updated)

  The findings, presented during a poster session at the EASL 2022 International Liver Congress, revealed that of the 407 D-LIVR participants, nearly 30% developed liver cirrhosis.

  June 28, 2022

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Business

  Beyond Increments: Black Perspectives on Representation in the Life Sciences

  BioSpace spoke with several Black individuals working within the life sciences to get their thoughts on the current representative disconnect and what they believe can be done to fix it.

  June 28, 2022

   · 

  10 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Spero Searching for Way Forward after FDA Rejects cUTI Drug

  Spero Therapeutics received a Complete Response Letter from the U.S. Food and Drug Administration for its complicated urinary tract infection therapy, tebipenem HBr oral tablets.

  June 28, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Astellas and Sutro Unite to Overcome Checkpoint Inhibitor Limitations with iADCs

  Astellas Pharma and Sutro Biopharma inked a global collaboration and licensing deal to work to discover and develop novel immunostimulatory antibody-drug conjugates.

  June 28, 2022

   · 

  3 min read

   · 

  Mark Terry